Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes

Details for Australian Patent Application No. 2008202638 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008202638

Parent 2003228508

Filing date 13 June 2008

Wipo publication date 3 July 2008

Acceptance publication date 22 December 2011

International Classifications

A61K 31/454 (2006.01)

A61K 31/07 (2006.01)

A61K 31/285 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/573 (2006.01)

A61K 31/724 (2006.01)

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

3 July 2008 Application Open to Public Inspection

  Published as AU-B-2008202638

3 July 2008 Complete Application Filed

22 December 2011 Application Accepted

  Published as AU-B-2008202638

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008202639-Methods and devices for playing a modified baccarat game

2008202637-Umbilcal deployment system